Directory
>
Stanley Erck
Stanley Erck
Vice President, Corporate Development | Novavax
South Carolina, Bluffton, United States
Stanley Erck
Summary
Stanley Erck is an accomplished executive in the biotechnology sector with extensive experience leading companies focused on infectious diseases and cancer treatment. He has held pivotal roles, including CEO and board member at various influential biotech firms, where he has successfully guided product development from conception to market. His strategic vision and expertise in corporate development have been instrumental in advancing innovative healthcare solutions. Stanley's educational background includes an MBA from the University of Chicago Booth School of Business, which complements his practical experience in the industry. He is currently serving as a member of the Board of Directors at Novavax, where he continues to influence the future of biotechnology. In addition to his leadership roles, he has a strong interest in efficiency and technology applications within the field. His career spans over several decades, showcasing a commitment to improving patient outcomes through scientific advancements.
Stanley Erck
Work Experience
Advisor to the Board of Directors, Former CEO at
Novavax
January 2009 - Present
Stanley Erck
Education
University of Chicago Booth School of Business, MBA, Economics, Finance
January 1973 - January 1976
Frequently Asked Questions about Stanley Erck
What is Stanley Erck email address?
Stanley Erck's primary email address is *****@maxcyte.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Stanley Erck work for?
Stanley Erck is a Vice President, Corporate Development at Novavax.
Where Stanley Erck graduated from?
Stanley Erck holds a degree in null from University of Chicago Booth School of Business.
How can I directly contact Stanley Erck?
To contact Stanley Erck directly, you can use the email address *****@maxcyte.com. Complete contact information is available upon registration with Muraena.
Who is Stanley Erck?
Stanley Erck is an accomplished executive in the biotechnology sector with extensive experience leading companies focused on infectious diseases and cancer treatment. He has held pivotal roles, including CEO and board member at various influential biotech firms, where he has successfully guided product development from conception to market. His strategic vision and expertise in corporate development have been instrumental in advancing innovative healthcare solutions. Stanley's educational background includes an MBA from the University of Chicago Booth School of Business, which complements his practical experience in the industry. He is currently serving as a member of the Board of Directors at Novavax, where he continues to influence the future of biotechnology. In addition to his leadership roles, he has a strong interest in efficiency and technology applications within the field. His career spans over several decades, showcasing a commitment to improving patient outcomes through scientific advancements.
Stanley`s contact details
*****@maxcyte.com
*****@novavax.com
Colleagues
Business Analyst
Associate Director, Health Care Member Services
Professor of Pediatrics and Microbiology
Vice President and Head of Worldwide Regulatory Affairs Vaccine development
PRISM Product Development and Support
Pediatric Resident
Staffing Account Manager
Principal Scientist
Systems Analyst